Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis

There have been few studies on relapse after a sustained virological response in hepatitis C virus (HCV) patients treated with interferon-free regimens. Thus, the risk of late relapse in patients treated with interferon-free therapy remains unclear. A 67-year-old woman with HCV genotype 1b and liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Uojima, Haruki, Murakami, Shuko, Nakatani, Seigo, Hidaka, Hisashi, Takeuchi, Atsuko, Tanaka, Yoshiaki, Inoue, Tomoyoshi, Yamane, Keiko, Kubota, Kousuke, Nakazawa, Takahide, Shibuya, Akitaka, Tanaka, Yasuhito, Koizumi, Wasaburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919851/
https://www.ncbi.nlm.nih.gov/pubmed/29225269
http://dx.doi.org/10.2169/internalmedicine.9671-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919851/
https://www.ncbi.nlm.nih.gov/pubmed/29225269
http://dx.doi.org/10.2169/internalmedicine.9671-17

Ejemplares similares